NEW YORK (GenomeWeb) – Backed by a recent $3 million fundraise, Ceres Nanosciences is looking to further develop its Lyme disease diagnostic with an eye toward moving it into settings like doctors' offices and pharmacy clinics.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.